← Back to headlines
Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments
Truist Securities has downgraded Harmony Biosciences Holdings, Inc. (HRMY) to a 'Hold' rating following recent developments in a patent trial.
26 Feb, 13:57 — 26 Feb, 13:57
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Nigeria Deposit Insurance Corporation (NDIC) Reports 2025 Budget Execution and 2026 Proposal
just now
HELLENiQ ENERGY Reports Strong 2025 Financial Results
11m ago
Chemed cut to Neutral at BofA after Q4 miss
14m ago
Athens Stock Exchange: 12 Blue Chips Defy Correction and Continue Record Performance
17m ago